Amazing Meds Review
Best for: patients seeking compounded retatrutide access (with eyes open about regulatory status)
Amazing Meds is a Colorado Springs-based telehealth and wellness clinic offering compounded semaglutide, tirzepatide, and — uniquely — compounded retatrutide alongside HRT and peptide therapy. Board-certified D.O. medical director, free consultations, and limited insurance acceptance (Cigna, BCBS). Notable for being one of the very few US clinics openly prescribing compounded retatrutide while it is still in Phase 3 trials.
WeightLossRankings.org is reader-supported. When you buy through links on our site, we may earn an affiliate commission. Learn more
The Bottom Line
Amazing Meds is a solid telehealth option with balanced features and pricing.
Score Breakdown
Pricing
| Dose | Form | Price/mo |
|---|---|---|
| 0.25mg | compounded | $199 |
| 1mg | compounded | $299 |
| 2.5mg | compounded | $349 |
✓ Pros
- •One of the very few US clinics offering compounded retatrutide
- •Board-certified D.O. medical director
- •Limited insurance acceptance (Cigna, BCBS)
- •Free consultations
✗ Cons
- •Compounded retatrutide is regulatorily ambiguous (Phase 3 investigational drug)
- •Lower trust score because retatrutide is not FDA-approved and lacks the safety dataset of approved GLP-1s
Ready to start with Amazing Meds?
Starting at $199/month. See current pricing and start your free consultation.
Sources & methodology
Our Amazing Meds review applies the same 6-dimension scoring framework we use for every provider. Pricing, FDA approval status, compounding rules, and clinical-trial efficacy claims are sourced from the primary regulatory and peer-reviewed literature below.
Sources & methodology — as of April 2026
- 1.Weight Loss Rankings — GLP-1 Pricing Index 2026 (our independent dataset)— WeightLossRankings.org.
- 2.FDA — Compounding and the 503A Pharmacy Framework— U.S. Food & Drug Administration.
- 3.FDA — Drug Shortages Database (current shortage listings)— U.S. Food & Drug Administration.
- 4.PCAB — Pharmacy Compounding Accreditation Board Standards— Accreditation Commission for Health Care (ACHC) / PCAB.
- 5.KFF — Medicaid coverage research (anti-obesity & GLP-1 drug policy)— Kaiser Family Foundation.
- 6.STEP 1 Trial — Once-Weekly Semaglutide in Adults with Overweight or Obesity (Wilding JPH et al.)— New England Journal of Medicine.PMID: 33567185.
- 7.FDA — Wegovy (semaglutide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
- 8.FDA — Ozempic (semaglutide) Prescribing Information via Drugs@FDA— U.S. Food & Drug Administration.
- 9.SURMOUNT-1 Trial — Tirzepatide Once Weekly for the Treatment of Obesity (Jastreboff AM et al.)— New England Journal of Medicine.PMID: 35658024.
- 10.FDA — Zepbound (tirzepatide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
- 11.FDA — Mounjaro (tirzepatide) Prescribing Information via Drugs@FDA— U.S. Food & Drug Administration.
- 12.SURMOUNT-5 Trial — Tirzepatide vs. Semaglutide Head-to-Head in Obesity (Garvey WT et al.)— New England Journal of Medicine.PMID: 40334173.
Alternatives to Amazing Meds
Alan Meds
Best for: budget-conscious shoppers
AmberHealth
Best for: budget-conscious shoppers
Amble
Best for: mainstream telehealth GLP-1 access
Frequently Asked Questions
Ready to start with Amazing Meds?
Starting at $199/month. See current pricing and start your free consultation.